Raw Data Library
About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User Guide
Green Science
​
​
EN
Sign inGet started
​
​

About
Aims and ScopeAdvisory Board Members
More
Who We Are?
User GuideGreen Science

Language

Sign inGet started
RDL logo

Verified research datasets. Instant access. Built for collaboration.

Navigation

About

Aims and Scope

Advisory Board Members

More

Who We Are?

Add Raw Data

User Guide

Legal

Privacy Policy

Terms of Service

Support

Got an issue? Email us directly.

Email: info@rawdatalibrary.netOpen Mail App
​
​

© 2025 Raw Data Library. All rights reserved.
PrivacyTerms
  1. Raw Data Library
  2. /
  3. Publications
  4. /
  5. Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial

Verified authors • Institutional access • DOI aware
50,000+ researchers120,000+ datasets90% satisfaction
Article
en
2021

Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial

0 Datasets

0 Files

en
2021
Vol 9 (9)
Vol. 9
DOI: 10.1016/s2213-2600(21)00134-x

Get instant academic access to this publication’s datasets.

Create free accountHow it works

Frequently asked questions

Is access really free for academics and students?

Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.

How is my data protected?

Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.

Can I request additional materials?

Yes, message the author after sign-up to request supplementary files or replication code.

Advance your research today

Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.

Get free academic accessLearn more
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
Access Research Data

Join our academic network to download verified datasets and collaborate with researchers worldwide.

Get Free Access
Institutional SSO
Secure
This PDF is not available in different languages.
No localized PDFs are currently available.
Zhong Lin Wang
Zhong Lin Wang

Beijing Institute of Technology

Verified
Jianxing He
Chunxia Su
Wenhua Liang
+30 more

How to cite this publication

Jianxing He, Chunxia Su, Wenhua Liang, Shidong Xu, Lin Wu, Xiangning Fu, Xu Dong Zhang, Di Ge, Qun Chen, Weimin Mao, Lin Xu, Chun Chen, Bing Hu, Guoguang Shao, Jian Hu, Jian Zhao, Xiaoqing Liu, Zhidong Liu, Zheng Wang, Zemin Xiao, Taiqian Gong, Wen Lin, Xingya Li, Feng Ye, Yang Liu, Haitao Ma, Yunchao Huang, Jianying Zhou, Zhong Lin Wang, Junke Fu, Lieming Ding, Li Mao, Caicun Zhou (2021). Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial. , 9(9), DOI: https://doi.org/10.1016/s2213-2600(21)00134-x.

Related publications

Why join Raw Data Library?

Quality

Datasets shared by verified academics with rich metadata and previews.

Control

Authors choose access levels; downloads are logged for transparency.

Free for Academia

Students and faculty get instant access after verification.

Publication Details

Type

Article

Year

2021

Authors

33

Datasets

0

Total Files

0

Language

en

DOI

https://doi.org/10.1016/s2213-2600(21)00134-x

Join Research Community

Access datasets from 50,000+ researchers worldwide with institutional verification.

Get Free Access